PMC:7386785 / 121991-123006 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T501","span":{"begin":25,"end":29},"obj":"Disease"},{"id":"T502","span":{"begin":68,"end":72},"obj":"Disease"},{"id":"T503","span":{"begin":324,"end":332},"obj":"Disease"},{"id":"T504","span":{"begin":333,"end":342},"obj":"Disease"},{"id":"T505","span":{"begin":438,"end":447},"obj":"Disease"},{"id":"T506","span":{"begin":526,"end":535},"obj":"Disease"}],"attributes":[{"id":"A501","pred":"mondo_id","subj":"T501","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A502","pred":"mondo_id","subj":"T502","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A503","pred":"mondo_id","subj":"T503","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A504","pred":"mondo_id","subj":"T504","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A505","pred":"mondo_id","subj":"T505","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A506","pred":"mondo_id","subj":"T506","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T150","span":{"begin":79,"end":83},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T151","span":{"begin":268,"end":275},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T152","span":{"begin":608,"end":609},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T153","span":{"begin":712,"end":714},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T154","span":{"begin":770,"end":772},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T155","span":{"begin":786,"end":788},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T156","span":{"begin":975,"end":982},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T22","span":{"begin":234,"end":236},"obj":"Chemical"}],"attributes":[{"id":"A55012","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_73503"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T416","span":{"begin":344,"end":349},"obj":"Phenotype"},{"id":"T417","span":{"begin":354,"end":359},"obj":"Phenotype"},{"id":"T418","span":{"begin":363,"end":382},"obj":"Phenotype"}],"attributes":[{"id":"A416","pred":"hp_id","subj":"T416","obj":"http://purl.obolibrary.org/obo/HP_0001945"},{"id":"A417","pred":"hp_id","subj":"T417","obj":"http://purl.obolibrary.org/obo/HP_0012735"},{"id":"A418","pred":"hp_id","subj":"T418","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1516","span":{"begin":158,"end":383},"obj":"Sentence"},{"id":"T1517","span":{"begin":384,"end":508},"obj":"Sentence"},{"id":"T1518","span":{"begin":509,"end":591},"obj":"Sentence"},{"id":"T1519","span":{"begin":592,"end":671},"obj":"Sentence"},{"id":"T1520","span":{"begin":672,"end":709},"obj":"Sentence"},{"id":"T1521","span":{"begin":710,"end":748},"obj":"Sentence"},{"id":"T1522","span":{"begin":749,"end":779},"obj":"Sentence"},{"id":"T1523","span":{"begin":780,"end":798},"obj":"Sentence"},{"id":"T1524","span":{"begin":799,"end":817},"obj":"Sentence"},{"id":"T1525","span":{"begin":818,"end":845},"obj":"Sentence"},{"id":"T1526","span":{"begin":846,"end":871},"obj":"Sentence"},{"id":"T1527","span":{"begin":872,"end":892},"obj":"Sentence"},{"id":"T1528","span":{"begin":893,"end":1015},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}

{"project":"LitCovid-PubTator","denotations":[{"id":"2151","span":{"begin":25,"end":35},"obj":"Species"},{"id":"2152","span":{"begin":68,"end":78},"obj":"Species"},{"id":"2153","span":{"begin":211,"end":219},"obj":"Species"},{"id":"2154","span":{"begin":279,"end":287},"obj":"Species"},{"id":"2155","span":{"begin":596,"end":603},"obj":"Species"}],"attributes":[{"id":"A2151","pred":"tao:has_database_id","subj":"2151","obj":"Tax:2697049"},{"id":"A2152","pred":"tao:has_database_id","subj":"2152","obj":"Tax:2697049"},{"id":"A2153","pred":"tao:has_database_id","subj":"2153","obj":"Tax:9606"},{"id":"A2154","pred":"tao:has_database_id","subj":"2154","obj":"Tax:9606"},{"id":"A2155","pred":"tao:has_database_id","subj":"2155","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Facility cases: positive SARS‐CoV‐2 testFacility controls: negative SARS‐CoV‐2 test, visiting the same EDs and being testedCountry: USA (San Diego, CA)Dates: 10 March 2020‐19 March 2020Symptoms and severity:all patients presenting to ED who were eligible for targeted testing (= patients presenting with symptoms related to COVID‐19 infection (fever and cough or shortness of breath)\ntravel within 14 days to countries with high rates of infection (at that time China, Iran, Italy, Japan, and South Korea) or\nrisk factors for infection complications (including age or comorbid conditions) or\nthe patient was a healthcare worker who could potentially expose others at risk\ncomorbidities 101/235 (43.0%) (cases: 8/27 (29.6%), controls 93/208 (44.7%))\nDemographics: age (\u003c 18 years: 0.7%, 18‐64 years: 83.4%, \u003e 65 years: 15.9%); gender: cases M/F%: 55.2/44.8; controls M/F%: 52.8/47.2; all M/F%: 53.0/47.0Exposure history: recent travel (5.5%), 90.6% symptom‐based criteria for testing, no known exposure history based"}